Investing Profile
Chris Borella
Your Intro Paths to Chris Borella
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Chris is a member of
Stony Brook University Network
28 CONNECTIONS
Current Investing Position
Gordian Ventures Venture Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Chris Borella is on these Sector & Stage Rankings
Chris Borella's Experience
Project Leader/Sr. Scientist Proteostasis Therapeutics Inc.Present
Associate Director, Program Management Agios PharmaceuticalsPresent
MAT2A Project Team Leader, Head of Early Stage Program Management Agios PharmaceuticalsPresent
Vice President, Head of Operations Silicon Therapeutics (Acquired by Roivant Sciences)Present
Consultant Chengwei CapitalPresent
Chief Operating Officer (Consultant) StingtheraPresent
Board Member Cognesy TherapeuticsPresent
Chief Operating Officer Tesseract MedicinesPresent
Consultant Gordian VenturesPresent
Drug Maker, Program Management and Operations Curie.BioPresent
Senior Vice President Strategy Full-Life TechnologiesPresent
COO, Co-founder Stealth Company (Chris Borella)Present
Co-founder, Partner & COO Gordian VenturesPresent
Partner & COO Gordian VenturesPresent
Co-Founder, interim CEO and Board Member Synta PharmaceuticalsPresent
Co-Founder, interim CEO/COO & Board Member Tesseract MedicinesPresent
Co-Founder & Board Member Tesseract MedicinesPresent
Venture Partner Gordian VenturesPresent
Chris Borella's Education
Rowan University BS Chemistry
Stony Brook University PhD Medicinal Chemistry
Investors who invest with Chris Borella
Sign in with Google →Scouts & Angels Affiliated With Chris Borella
Sign in with Google →